Cargando…

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review

Life expectancy for persons with hemophilia has increased over recent decades due to advances in treatment practice and patient care. Those with hemophilia are now more likely to be affected by conditions associated with aging, such as myocardial infarction, hemorrhagic/ischemic stroke, deep vein th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapiro, Amy D., Hardesty, Brandon M., Peyvandi, Flora, Iorio, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986102/ https://www.ncbi.nlm.nih.gov/pubmed/36891522 http://dx.doi.org/10.1016/j.rpth.2022.100007

Ejemplares similares

Product type and other environmental risk factors for inhibitor development in severe hemophilia A
por: Peyvandi, Flora, et al.
Publicado: (2018)

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics
por: Zhou, Jenny Y., et al.
Publicado: (2019)

The Arrival of Gene Therapy for Patients with Hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2022)

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database
por: Pipe, Steven W., et al.
Publicado: (2020)

Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
por: Garcia, Jessica, et al.
Publicado: (2023)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Bleeding and thrombotic events in post-cardiotomy extracorporeal life support
por: Schaefer, Anne-Kristin, et al.
Publicado: (2023)

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
por: Yu, Jacky K., et al.
Publicado: (2019)

The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review
por: Boccalandro, Elena A., et al.
Publicado: (2022)

Updates on Novel Non-Replacement Drugs for Hemophilia
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
por: Castaman, Giancarlo, et al.
Publicado: (2023)

Acquired Hemophilia A with Gastrointestinal Bleeding
por: Park, Narae, et al.
Publicado: (2020)

Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH
por: Konkle, Barbara, et al.
Publicado: (2020)

Differences in Major Bleeding Events Between Patients With Severe Hemophilia A and Hemophilia B: A Nationwide, Population-Based Cohort Study
por: Shih, Ming-Yang, et al.
Publicado: (2020)

Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3
por: Callaghan, Michael U., et al.
Publicado: (2022)

Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII
por: Jonsson, Fredrik, et al.
Publicado: (2021)

The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
por: Sun, Haowei (Linda), et al.
Publicado: (2021)

Bleeding Versus Thrombotic Tendency in Young Children With Beta-Thalassemia Major
por: Singh, Shalini, et al.
Publicado: (2021)

Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
por: Capecchi, Marco, et al.
Publicado: (2020)

Handwriting Analysis in Children and Adolescents with Hemophilia: A Pilot Study
por: Pasta, Gianluigi, et al.
Publicado: (2020)

Prevention and Management of Bleeding Episodes in Children with Hemophilia
por: Ljung, Rolf C. R.
Publicado: (2018)

An Unusual Case of Bleeding: Acquired Hemophilia A
por: Jahangiri, Omeed S, et al.
Publicado: (2023)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021)

Hemophilia gene therapy knowledge and perceptions: Results of an international survey
por: Peyvandi, Flora, et al.
Publicado: (2020)

Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients
por: Liu, Yupeng, et al.
Publicado: (2022)

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database
por: Peyvandi, Flora, et al.
Publicado: (2020)

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting
por: Ay, Cihan, et al.
Publicado: (2020)

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
por: O'Sullivan, Jamie M, et al.
Publicado: (2020)

Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A
por: Retout, Sylvie, et al.
Publicado: (2020)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Hemophilia trials in the twenty‐first century: Defining patient important outcomes
por: Konkle, Barbara A., et al.
Publicado: (2019)

Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021)

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A
por: Klamroth, Robert, et al.
Publicado: (2022)

Prevalence of Disease and Relationships between Laboratory Phenotype and Bleeding Severity in Platelet Primary Secretion Defects
por: Lotta, Luca A., et al.
Publicado: (2013)

Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
por: Riva, Silvia, et al.
Publicado: (2020)

Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A
por: Knöbl, Paul
Publicado: (2018)

Undiagnosed Acquired Hemophilia A: Presenting as Recurrent Gastrointestinal Bleeding
por: Roy, Arya Mariam, et al.
Publicado: (2020)

Acquired Hemophilia A: A Potentially Fatal Bleeding Disorder
por: Singh, Navdeep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_of6ddshso8666i5c3mji83vmdl